2005
DOI: 10.1016/j.brainres.2004.12.025
|View full text |Cite
|
Sign up to set email alerts
|

Effects of the Ca2+ antagonist nimodipine on functional deficits in the peripheral and central nervous system of streptozotocin-diabetic rats

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
16
0

Year Published

2006
2006
2014
2014

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 26 publications
(16 citation statements)
references
References 31 publications
0
16
0
Order By: Relevance
“…In the present study, DH exaggerated neuronal loss in lithium-pilocarpine-induced SE. In addition to SE-related excitotoxicity (Curia et al 2008), DH plus SE may amplify the adverse effects of hyperglycemia on neurons, both the direct effects and the indirect effects, such as diabetic oxidative stress (Zupan et al 2008), microvascular changes (Mraovitch et al 2005;Qiu et al 2008), and altered calcium homeostasis (Raza et al 2004;Biessels et al 2005). As neuronal glucose uptake depends on the extracellular concentration of glucose, cellular damage can ensue after persistent episodes of hyperglycemia (Tomlinson and Gardiner 2008).…”
Section: Discussionmentioning
confidence: 98%
“…In the present study, DH exaggerated neuronal loss in lithium-pilocarpine-induced SE. In addition to SE-related excitotoxicity (Curia et al 2008), DH plus SE may amplify the adverse effects of hyperglycemia on neurons, both the direct effects and the indirect effects, such as diabetic oxidative stress (Zupan et al 2008), microvascular changes (Mraovitch et al 2005;Qiu et al 2008), and altered calcium homeostasis (Raza et al 2004;Biessels et al 2005). As neuronal glucose uptake depends on the extracellular concentration of glucose, cellular damage can ensue after persistent episodes of hyperglycemia (Tomlinson and Gardiner 2008).…”
Section: Discussionmentioning
confidence: 98%
“…There have been promising effects of drugs that target glucocorticoids (Stranahan et al, 2010), GLP-1 (Gault et al, 2010; Iwai et al, 2009), glucose-dependent insulinotropic polypeptide (Porter et al, 2011), and glucose control (Izumi et al, 2003). Initiation of treatment shortly after diabetes induction with enalapril, an angiotensin-converting enzyme inhibitor, and nimodipine, a calcium channel blocker, prevented diabetes-induced alterations in LTP but delayed treatment was not able to reverse already existing hippocampal damage (Biessels et al, 2005; Manschot et al, 2003). The results of these studies imply that there may be a window of opportunity to reverse neurobehavioral complications from diabetes.…”
Section: Experimental Diabetes and Other Forms Of Hippocampal Neurmentioning
confidence: 99%
“…It has been reported that nimodipine ameliorates existing experimental diabetic neuropathy in diabetic rats (Kappelle et al, 1993). Nimodipine treatment improves Ca 2+ -dependent forms of synaptic plasticity in the hippocampus of diabetic rats (Biessels et al, 2002), partially prevents deficits in nerve conduction velocity and hippocampal long-term potentiation (Biessels et al, 2005). Recent results indicate that nimodipine can improve experimental diabetic neuropathy through a vascular mechanism, possibly in combination with direct neuronal effects (Biessels et al, 2002).…”
Section: Introductionmentioning
confidence: 97%